Cancer Immunotherapy Market Insights
Cancer immunotherapy market is projected to be worth USD 271.84 Billion by 2030, registering a CAGR of 13.7 % during the forecast period (2022-2030), The market was valued at USD 85.60 Billion in 2021. The monoclonal antibodies segment has gained the greatest share in 2020. Owing to an increase in use for cancer immunotherapy. The lung cancer market held the greatest share in 2021 and is likely to lead the market during the study period due to the high prevalence of lung cancer worldwide. In regional segment, North America contributed the largest market share in 2021, due to increase in healthcare spending.
Cancer Immunotherapy Market Dynamics:
Cancer immunotherapy is a procedure used in the treatment of cancer that employs the body’s immune system to support the battle against cancer. Cancer cells can infiltrate the immune system via a variety of methods. Immunotherapy focuses on these pathways while also developing new paths to restore the immune system’s capacity to attack cancer cells.
Driver:
The rising prevalence of cancer globally is fueling the growth of the cancer immunotherapy market. Further, emergence of biosimilar, increasing demand for target therapy over traditional therapy, increasing demand for monoclonal antibodies are driving the growth of the cancer immunotherapy market.
Restraint:
Stringent rules and regulations imposed on cancer immunotherapy treatment and low awareness among individuals regarding advanced treatment are the factors hampering the growth of the cancer immunotherapy market.
Opportunity:
Increasing the adoption of cancer immunotherapy treatment in developed economies, and the advancement in bioinformatics is expected to boost the growth opportunities of the cancer immunotherapy market.
COVID-19 Analysis of Cancer Immunotherapy Market:
The cancer immunotherapy market has been significantly impacted due to the COVID-19 pandemic in many different parts of the world. Shipments were impacted during the initial lockdown due to a labor shortage and the closure of a manufacturing facility. The pandemic’s initial effects in China were tremendous. However, the nation’s circumstances have stabilized, and all product and service production rates have increased. As a result, it is determined that COVID-19’s overall impact on the cancer immunotherapy market is moderate. Post covid-19 there was a positive impact on the cancer immunotherapy market as consumers were more focused on health, which increased the demand for cancer immunotherapy.
Cancer Immunotherapy Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 271.84 |
| CAGR (2022-2030) | 13.7% |
| By Technology | Monoclonal Antibodies, Cytokines & Immunomodulators, Others |
| By Application | Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer, Others |
| By End-Use | Hospitals, Cancer Research Centers, Clinics |
| By geography | North America– (U.S., Canada, Mexico
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | Amgen, Inc., AstraZeneca, PLC, Bayer AG, Bristol-Myers Squibb Company, Eli Lily And Company, F. Hoffmann-La Roche, Ltd. (Genentech, Inc.), Pfizer, Inc., Johnson & Johnson (Janssen Global Services, LLC), Merck KGAANovartis AG |
Cancer Immunotherapy Market Segment Analysis:
By Technology
The market is segmented by technology type into monoclonal antibodies, cytokines & immunomodulators, and others. The monoclonal antibodies segment has gained the greatest share in 2020. Owing to an increase in use for cancer immunotherapy as they display distinct qualities where the immune system is controlled to activate or inhibit the molecules targeted on the immune system. Furthermore, monoclonal antibodies stimulate the anticancer immune response which in turn drives the growth of the cancer immunotherapy market.
By Application
The cancer immunotherapy market is divided into five applications such as breast cancer, lung cancer, prostate cancer, head and neck cancer, colorectal cancer, melanoma, and others. The lung cancer market held the greatest share in 2021 and is likely to lead the market during the study period due to the high prevalence of lung cancer worldwide. For instance, as per WHO 2.21 million cases were reported globally in 2020 and the number is expected to increase in the future. Further, an increase in awareness programs about the need for early detection of lung cancer, new therapies, and government policies is expected to strengthen the growth of the market.
End-Use
The market is divided into three segments based on end-user such as hospitals, cancer research institutions, and clinics. Due to the widespread usage of cancer immunotherapy in hospitals, healthcare facilities held the greatest market share of the cancer immunotherapy market in 2021, and this category is expected to increase at the fastest rate over the forecast period. Furthermore, increased demand for hospitals, reimbursement policies in hospitals, and patient convenience is expected to drive category growth during the projection period. Furthermore, hospitals will have the greatest CAGR of 14.7% during the predicted period. Hence, the above-mentioned factors drive the growth of the cancer immunotherapy market.
By Region
The cancer immunotherapy market is divided into four regions such as North America, Europe, Asia-Pacific, and Latin America. In 2021, North America contributed the largest market share. This is due to a sharp increase in healthcare spending, a greater emphasis on sustaining the greatest healthcare system, and a growth in cancer incidence worldwide. Further, the presence of key players in the region such as Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Merck, and Pfizer is fueling the growth of the cancer immunotherapy market. Additionally, the high purchase power of individuals and extensive healthcare policy in the region is expected to contribute to the growth of the cancer immunotherapy market.
Cancer Immunotherapy Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), product innovation, various business strategies, and Application launches have accelerated the growth of the Sample Preparation market. Key players in the market include-
- Amgen, Inc.
- Bayer AG
- AstraZeneca, PLC
- Bristol-Myers Squibb Company
- Eli Lily And Company
- Hoffmann-La Roche, Ltd. (Genentech, Inc.)
- Pfizer, Inc.
- Johnson & Johnson (Janssen Global Services, LLC)
- Merck KGAA
- Novartis AG.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Cancer Immunotherapy
- Global Cancer Immunotherapy Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Cancer Immunotherapy Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Distribution Channel
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Technology Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Cancer Immunotherapy demand
- Post-Covid Impact on Cancer Immunotherapy Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Cancer Immunotherapy Market Segmentation, by Revenue (USD Billion), (2022-2030)
- By Type
- Monoclonal Antibodies
- Cytokines & Immunomodulators
- Others
- By Application
- Lung Cancer
- Breast Cancer
- Colorectal Cancer
- Melanoma
- Prostate Cancer
- Head & Neck Cancer
- Others
- By End Use
- Hospitals
- Cancer Research Centers
- Clinics
- By Type
- Global Cancer Immunotherapy Market Overview, By Region
- North America Cancer Immunotherapy Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Type
- By Application
- By End Use
- Canada
- Mexico
- US
- Europe Cancer Immunotherapy Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Cancer Immunotherapy Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Cancer Immunotherapy Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Cancer Immunotherapy Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Cancer Immunotherapy Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Cancer Immunotherapy Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Amgen, Inc.
- Business Overview
- Business Financials (USD billion)
- Product Category, Type, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Astrazeneca, PLC
- Bayer AG
- Bristol-Myers Squibb Company
- Eli Lily And Company
- Hoffmann-La Roche, Ltd. (Genentech, Inc.)
- Pfizer, Inc.
- Johnson & Johnson (Janssen Global Services, LLC)
- Merck KGAA
- Novartis AG
- Amgen, Inc.
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.